Pfizer spends $6.7bn to enter the medical cannabis industry

Pfizer, the company behind one of the coronavirus vaccines, has announced the acquisition of a biotech company, marking their entrance into the ever-evolving medical cannabis scene. Forbes reports that Pfizer, an American multinational pharmaceutical and biotechnology corporation, has acquired all the outstanding shares of Arena Pharmaceutical for $100 per share in an all-cash deal, valuing […]